Evidence map›Paper›PMID 25445492›Full record

ArticleNeuropharmacology2015

Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity.

Daniel Jenson, Kechun Yang, Alexandra Acevedo-Rodriguez, Amber Levine, John I Broussard, Jianrong Tang, John A Dani

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effects of Methylphenidate on the Dopamine Transporter and Beyond.Current topics in behavioral neurosciences · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Methylphenidate modifies activity in the prefrontal and parietal cortex accelerating the time judgment.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel JensonDepartment of Neuroscience, Center on Addiction, Learning, Memory, Baylor College of Medicine, Houston, TX 77030, USA.
Kechun YangDepartment of Neuroscience, Mahoney Institute for Neurosciences, Perelman School of Medicine, Philadelphia, PA 19104, USA.
Alexandra Acevedo-RodriguezDepartment of Neuroscience, Center on Addiction, Learning, Memory, Baylor College of Medicine, Houston, TX 77030, USA.
Amber LevineDepartment of Neuroscience, Center on Addiction, Learning, Memory, Baylor College of Medicine, Houston, TX 77030, USA.
John I BroussardDepartment of Neuroscience, Center on Addiction, Learning, Memory, Baylor College of Medicine, Houston, TX 77030, USA.
Jianrong TangJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
John A DaniDepartment of Neuroscience, Mahoney Institute for Neurosciences, Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: johndani@upenn.edu.
Baylor College of Medicine · USNeurosciences Institute · US

Funding

STRUCTURE/FUNCTION OF EXCITATORY SYNAPTIC CHANNELSR01NS021229 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 1987 to 2021
$5.3M
CELLULAR MECHANISMS OF NICOTINE ADDICTIONR01DA009411 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DANI, JOHN A. · 1997 to 2018
$5.0M
CHOLINERGIC INFLUENCES NEURONAL CIRCUIT EXCITABILITYR37NS021229 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI DANI, JOHN A. · 2000 to 2006
$2.1M
ELECTRICALLY SIZING AND MODIFYING ION CHANNELSR23NS021229 · NINDS · YALE UNIVERSITY · PI DANI, JOHN A. · 1985 to 1986
–
NIDA NIH HHS DA09411NIDA NIH HHS R01 DA009411NINDS NIH HHS NS21229NINDS NIH HHS R01 NS021229NINDS NIH HHS R37 NS021229
6 · The paper itself

Abstract

Attention-deficit hyperactive disorder (ADHD) is the most commonly studied and diagnosed psychiatric disorder in children. Methylphenidate (MPH, e.g., Ritalin) has been used to treat ADHD for over 50 years. It is the most commonly prescribed treatment for ADHD, and in the past decade it was the drug most commonly prescribed to teenagers. In addition, MPH has become one of the most widely abused drugs on college campuses. In this study, we examined the effects of MPH on hippocampal synaptic plasticity, which serves as a measurable quantification of memory mechanisms. Field potentials were recorded with permanently implanted electrodes in freely-moving mice to quantify MPH modulation of perforant path synaptic transmission onto granule cells of the dentate gyrus. Our hypothesis was that MPH affects hippocampal synaptic plasticity underlying learning because MPH boosts catecholamine signaling by blocking the dopamine and norepinephrine transporters (DAT and NET respectively). In vitro hippocampal slice experiments indicated MPH enhances perforant path plasticity, and this MPH enhancement arose from action via D1-type dopamine receptors and β-type adrenergic receptors. Similarly, MPH boosted in vivo initiation of long-term potentiation (LTP). While there was an effect via both dopamine and adrenergic receptors in vivo, LTP induction was more dependent on the MPH-induced action via D1-type dopamine receptors. Under biologically reasonable experimental conditions, MPH enhances hippocampal synaptic plasticity via catecholamine receptors.

Indexed as

AnimalsCentral Nervous System StimulantsDentate GyrusDopamineDose-Response Relationship, DrugElectric StimulationElectrodes, ImplantedFemaleLong-Term PotentiationMaleMethylphenidateMice, Inbred C57BLNeuronsPatch-Clamp TechniquesPerforant PathwayReceptors, AdrenergicCentral Nervous System StimulantsDopamineMethylphenidateReceptors, AdrenergicReceptors, DopamineDentate gyrusLong-term potentiationLTPMemoryPerforant pathReward

Identifiers

PMID25445492
PMCPMC4533926
OpenAlexW2088570852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.